11 pending office actions • 2 clients
| Client (Assignee) | Pending OAs |
|---|---|
| Wave Life Sciences Ltd. | 10 |
| Mamoru Shimizu | 1 |
| App # | Title | Client | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|---|
| 18313032 | CHIRAL CONTROL | Wave Life Sciences Ltd. | BAKSHI, PANCHAM | 1623 | Non-Final OA | May 05, 2023 |
| 18178470 | OLIGONUCLEOTIDE COMPOSITIONS AND METHODS OF USE THEREOF | Wave Life Sciences Ltd. | DACE DENITO, ALEXANDRA GERALDINE | 1636 | Non-Final OA | Mar 03, 2023 |
| 18174127 | IMMUNOASSAYS FOR DETECTING WILD TYPE HUNTINGTIN PROTEIN AND METHODS OF TREATMENT EMPLOYING SUCH IMMUNOASSAYS | Wave Life Sciences Ltd. | CESARE, JOSEPH DAVID | 1675 | Non-Final OA | Feb 24, 2023 |
| 18022509 | CELLS AND NON-HUMAN ANIMALS ENGINEERED TO EXPRESS ADAR1 AND USES THEREOF | Wave Life Sciences Ltd. | WILSON, MICHAEL C | 1638 | Non-Final OA | Feb 21, 2023 |
| 18072296 | METHODS AND COMPOSITIONS OF BIOLOGICALLY ACTIVE AGENTS | Wave Life Sciences Ltd. | ZARA, JANE J | 1637 | Non-Final OA | Nov 30, 2022 |
| 17926967 | DOUBLE STRANDED OLIGONUCLEOTIDE COMPOSITIONS AND METHODS RELATING THERETO | Wave Life Sciences Ltd. | VANHORN, ABIGAIL LOUISE | 1636 | Non-Final OA | Nov 21, 2022 |
| 17956741 | OLIGONUCLEOTIDE COMPOSITIONS AND METHODS OF USE THEREOF | Wave Life Sciences Ltd. | SHIN, DANA H | 1635 | Final Rejection | Sep 29, 2022 |
| 17907895 | OLIGONUCLEOTIDE COMPOSITIONS AND METHODS THEREOF | Mamoru Shimizu | WHITEMAN, BRIAN A | 1636 | Non-Final OA | Aug 29, 2022 |
| 17881956 | COMPOSITIONS AND METHODS FOR PHOSPHORAMIDITE AND OLIGONUCLEOTIDE SYNTHESIS | Wave Life Sciences Ltd. | CRAIGO, BAHAR ALAWI | 1699 | Non-Final OA | Aug 05, 2022 |
| 17605998 | OLIGONUCLEOTIDE COMPOSITIONS AND METHODS OF USE THEREOF | Wave Life Sciences Ltd. | TRAN, CHRISTINA L | 1637 | Final Rejection | Oct 22, 2021 |
| 17426511 | OLIGONUCLEOTIDE COMPOSITIONS AND METHODS THEREOF | Wave Life Sciences Ltd. | TRAN, CHRISTINA L | 1637 | Non-Final OA | Jul 28, 2021 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial